2023-07-25T19:17:29-05:00 2022-12-31 232896692 BBD LLP 1835 MARKET STREET 3RD FLOOR PHILADELPHIA PA 19103 990 2022-01-01 236251648 AMERICAN ASSOCIATION FOR CANCER RESEARCH INC AMER 2154409300 615 CHESTNUT STREET 17TH FLOOR PHILADELPHIA PA 19106 MICHAEL STEWART VICE PRESIDENT, CFO 2154409300 2023-07-25 1 MICHAEL STEWART 999009999 0 JENNIFER SOLOT P00749373 2155677770 2023-07-25 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z MICHAEL STEWART 615 CHESTNUT STREET 17TH FLOOR PHILADELPHIA PA 19106 120672398 0 X WWW.AACR.ORG X 1907 NY PREVENT AND CURE CANCER THROUGH RESEARCH, EDUCATION, COMMUNICATION AND COLLABORATION. 23 23 280 5000 505602 148703 44875975 26628085 53007904 51198544 4475469 4193811 812201 1073070 103171549 83093510 20949530 22976597 0 0 25069795 25511654 0 0 1253000 22241754 34529909 68261079 83018160 34910470 75350 261131206 231693702 74978175 79424842 186153031 152268860 X THE MISSION OF THE AACR IS TO PREVENT AND CURE CANCER THROUGH RESEARCH, EDUCATION, COMMUNICATION, AND COLLABORATION. THROUGH ITS PROGRAMS AND SERVICES, THE AACR FOSTERS RESEARCH IN CANCER AND RELATED BIOMEDICAL SCIENCE; ACCELERATES THE DISSEMINATION OF NEW RESEARCH FINDINGS AMONG SCIENTISTS AND OTHERS DEDICATED TO THE CONQUEST OF CANCER; PROMOTES SCIENCE EDUCATION AND TRAINING; AND ADVANCES THE UNDERSTANDING OF CANCER ETIOLOGY, PREVENTION, DIAGNOSIS AND TREATMENT THROUGHOUT THE WORLD. 0 0 25056116 22484702 RESEARCH GRANTS, SCIENTIFIC AWARDS, FELLOWSHIPS AND CAREER DEVELOPMENT AWARDS. 20045833 385578 25626189 ANNUAL MEETING AND SPECIAL CONFERENCES ATTENDED BY MEMBERS AND NON-MEMBERS FOR THE PRESENTATION OF SCIENTIFIC RESEARCH. ALSO INCLUDES EDUCATIONAL WORKSHOPS FOR TRAINING YOUNG INVESTIGATORS. 13050911 18309868 PUBLICATIONS - PRODUCTION & DISTRIBUTION OF THE JOURNALS: "CANCER RESEARCH", "MOLECULAR CANCER RESEARCH", "CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION", "CLINICAL CANCER RESEARCH", "MOLECULAR CANCER THERAPEUTICS", "CANCER PREVENTION RESEARCH", "CANCER DISCOVERY", "CANCER TODAY", "CANCER IMMUNOLOGY RESEARCH AND "BLOOD CANCER DISCOVERY". 2136468 [1] SCIENCE POLICY AND GOVERNMENT AFFAIRS 4936535 [2] COMMUNICATIONS 2001928 106317 340272 [3] SPECIAL CONSTITUENCIES - CONSISTS OF SERVICES TO UNDER-REPRESENTED POPULATIONS (WOMEN, MINORITIES, UNDERGRADUATES) TO ENHANCE THEIR SCIENTIFIC CAREERS. 5102607 2448001 [4] SCIENTIFIC PROJECTS AND PROGRAMS 471160 [5] SURVIVOR PROGRAM 4474214 [6] MEMBERSHIP 1220690 [7] CANCER TODAY MAGAZINE 15869388 106317 7262487 74022248 1 1 0 1 0 0 0 0 0 1 1 1 0 1 1 1 0 1 0 0 1 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 335 0 1 280 1 1 1 1 CA 0 0 0 0 0 0 0 0 0 0 X 23 23 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AR CA CO CT DC FL GA HI IL KS KY LA ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X MICHAEL STEWART CHIEF FINANCIAL OFFICER 2154409300 615 CHESTNUT STREET 17TH FLOOR PHILADELPHIA PA 19106 X DR DAVID A TUVESON PRESIDENT (JAN-MAR) 5.00 2.00 X X 0 0 0 DR LISA COUSSENS PRESIDENT (APR-DEC) 5.00 2.00 X X 0 0 0 DR LISA COUSSENS PRESIDENT-ELECT (JAN-MAR) 5.00 2.00 X X 0 0 0 DR PHILIP GREENBERG PRESIDENT-ELECT (APR-DEC) 5.00 X X 0 0 0 DR ANTONI RIBAS PAST PRESIDENT (JAN-MAR) 5.00 X X 0 0 0 DR DAVID A TUVESON PAST PRESIDENT (APR-DEC) 5.00 2.00 X X 0 0 0 DR WILLIAM N HAIT TREASURER 5.00 2.00 X X 0 0 0 DR MARCIA R CRUZ-CORREA DIRECTOR (2019-2022) 2.00 X 0 0 0 DR KEITH T FLAHERTY DIRECTOR (2019-2022) 2.00 X 0 0 0 DR MARTINE F ROUSSEL DIRECTOR (2019-2022) 2.00 X 0 0 0 DR CHARLES SWANTON DIRECTOR (2019-2022) 2.00 X 0 0 0 DR SILVIA C FORMENTI DIRECTOR (2020-2023) 2.00 X 0 0 0 DR ELAINE FUCHS DIRECTOR (2020-2023) 2.00 X 0 0 0 DR ROY S HERBST DIRECTOR (2020-2023) 2.00 X 0 0 0 DR IRA MELLMAN DIRECTOR (2020-2023) 2.00 X 0 0 0 DR SUZANNE L TOPALIAN DIRECTOR (2020-2023) 2.00 X 0 0 0 DR NINA BHARDWAJ DIRECTOR (2021-2024) 2.00 X 0 0 0 DR LUIS DIAZ DIRECTOR (2021-2024) 2.00 X 0 0 0 DR SUSAN GALBRAITH DIRECTOR (2021-2024) 2.00 X 0 0 0 DR THOMAS LYNCH DIRECTOR (2021-2024) 2.00 X 0 0 0 DR LISA NEWMAN DIRECTOR (2021-2024) 2.00 X 0 0 0 DR CHRISTINA CURTIS DIRECTOR (2022-2025) 2.00 X 0 0 0 DR WILLIAM PAO DIRECTOR (2022-2025) 2.00 X 0 0 0 DR KIMBERLY STEGMAIER DIRECTOR (2022-2025) 2.00 X 0 0 0 DR ROBERT VONDERHEIDE DIRECTOR (2022-2025) 2.00 X 0 0 0 DR JOHN CARPTEN DIRECTOR (2021-2025) 2.00 X 0 0 0 DR MARGARET FOTI CHIEF EXECUTIVE OFFICER 35.00 5.00 X 896040 99560 57426 MICHAEL STEWART VICE PRESIDENT, CHIEF FINANCIAL OFFICER 35.00 5.00 X 369075 19425 53226 JON RETZLAFF VP. SCIENCE POLICY & GOV. AFFAIRS, CHIEF POLICY OF 40.00 X 368000 0 46672 CHRISTINE BATTLE VP. SCIENTIFIC PUBLICATIONS, PUBLISHER 40.00 X 290000 0 40988 PAUL DRISCOLL VP. MARKETING AND CREATIVE SERVICES 40.00 X 280000 0 48457 YIXIAN ZHANG SR. DIRECTOR / SCIENTIFIC REVIEW AND. 40.00 X 270000 0 47656 RICHARD BUCK VP. COMMUNICATION 40.00 X 270000 0 42623 JOSEPH PONTOSKI SR. MANAGING DIRECTOR / FINANCE 40.00 X 269000 0 42143 MARY BALLINGER MNG. DIRECTOR / MEETINGS AND EXHIBITS 40.00 X 230000 0 39171 3242115 118985 418362 72 0 1 0 FREEMAN PO BOX 650036 DALLAS TX 75265 AUDIO VISUAL SERVICES 3848779 615 CHESTNUT MASTER LEASE LP 615 CHESTNUT STREET PHILADELPHIA PA 19106 OFFICE LEASE 2364252 REACTION AUDIO VISUAL 30400 ESPERANZA RANCHO SANTA MARGARITA CA 92688 AUDIO VISUAL SERVICES 1202068 THE SHERIDAN PRESS PO BOX 414784 BOSTON MA 02241 PUBLICATION SERVICES 911400 SAGE BIONETWORKS 2901 3RD AVE SUITE 330 SEATTLE WA 98121 DATA DISTRIBUTION COORDINATION 739369 51 25847121 780964 26628085 CONFERENCES/WORKSHOPS 541800 25626189 19297414 282258 6046517 PUBLICATIONS 541800 18309868 18086524 223344 MEMBERSHIP 541800 4474214 4474214 SCIENTIFIC INITIATIVES 541800 2448001 2448001 340272 340272 51198544 1697176 1697176 1073070 1073070 40075523 37578888 2496635 2496635 2496635 83093510 44646425 505602 11313398 21710597 21710597 1266000 1266000 1367363 1160011 207352 19167406 16260800 2906606 1229526 1043077 186449 2359908 2002044 357864 1387451 1177053 210398 476223 411393 64830 314831 314831 1308265 1308265 4034825 3639182 395643 2201495 2106875 94620 1883854 1627111 256743 2367776 2156218 211558 1597197 1429669 167528 5837988 5272748 565240 1253000 1253000 319500 206723 112777 255218 237433 17785 AUDIO VISUAL SERVICES 4690324 4518519 171805 PRINTING 3667324 3506679 160645 HONORARIA 1330320 1330320 CREDIT CARD FEES 913147 835754 77393 2078622 1809211 269411 83018160 74022248 7742912 1253000 19723400 16270356 7818212 3394949 47606880 33360393 2393081 3482308 2024478 2286575 4706132 4468185 587667 237947 75386791 68096212 97141307 89664319 8449390 14900643 261131206 231693702 13730166 10899855 38551597 29367393 14307022 23558683 8389390 15598911 74978175 79424842 X 158906317 130896323 27246714 21372537 186153031 152268860 261131206 231693702 X 75350 -31975000 -1984521 X 0 1 X 1 1 1 X 60318039 65829907 48746614 44875975 26628085 246398620 46269669 49219425 53422477 48713405 44646425 242271401 5479195 5832153 334900 3729901 6046517 21422666 112066903 120881485 102503991 97319281 77321027 510092687 59377538 64815426 48631114 39834626 25847121 238505825 0 59377538 64815426 48631114 39834626 25847121 238505825 271586862 2338452 3121033 2188901 2160011 2770246 12578643 212864 36584 109445 117475 476368 2551316 3157617 2188901 2269456 2887721 13055011 114618219 124039102 104692892 99588737 80208748 523147698 0.51910 0.48480 0.02500 0.02170 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 125932 188899 314831 81082366 81397197 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 348905 254738 232513 314831 1150987 250000 250000 250000 250000 1000000 1500000 139562 101895 93005 125932 460394 6629161 8000 -1209194 194695 5233272 6535395 9500 413441 329175 6629161 5563755 144455 1007185 180000 6535395 5083898 3000 835857 359000 5563755 1767335 3744062 -231499 196000 5083898 0.49112 0.50889 0 0 877844 762153 115691 3828288 3706032 122256 237947 LIMITED PARTNERSHIPS 89664319 F 89664319 RECEIVABLE FROM FOUNDATION 7674469 OPERATING LEASES RIGHT-OF-USE-ASSET 7226174 14900643 PAYABLE TO AFFILIATE 7588554 OPERATING LEASES LIABILITY 8010357 15598911 X 50910343 -31975000 28200219 -3774781 54685124 1308265 27100121 28408386 83093510 84789678 30179904 30179904 54609774 1308265 27100121 28408386 83018160 PART V, LINE 4: THE INCOME FROM THE FUNDS IS AVAILABLE TO SUPPORT THE PROGRAMS, SERVICES AND MISSION OF THE ACCR. PART X, LINE 2: UNCERTAIN TAX POSITIONS UNDER ASC 740 GAAP PRESCRIBES A MINIMUM RECOGNITION THRESHOLD THAT A TAX POSITION IS REQUIRED TO MEET IN ORDER TO BE RECOGNIZED IN THE FINANCIAL STATEMENTS. AACR BELIEVES THAT THEY HAD NO UNCERTAIN TAX POSITIONS AS DEFINED IN GAAP. PART XI, LINE 2D - OTHER ADJUSTMENTS: REVENUE OF AFFILIATES 29,409,819. RETURN OF UNDISTRIBUTED PLEDGES -1,209,600. PART XI, LINE 4B - OTHER ADJUSTMENTS: INTERCOMPANY REVENUE 27,100,121. PART XII, LINE 2D - OTHER ADJUSTMENTS: EXPENSES OF AFFILIATES 30,179,904. PART XII, LINE 4B - OTHER ADJUSTMENTS: INTERCOMPANY EXPENSES 27,100,121. 1 NORTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION GRANT MAKING 40000 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION GRANT MAKING 480000 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS LOCATED IN REGIONGRANTS TO RECIPIENTS LOCATED IN REGION GRANT MAKING 206000 AUSTRALIA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION GRANT MAKING 320000 SUB-SAHARAN AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION GRANT MAKING 220000 CENTRAL AMERICA AND THE CARRIBEAN 0 0 OFFSHORE INVESTMENTS 9402000 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 OFFSHORE INVESTMENTS 3529000 0 0 0 0 0 0 14197000 0 14197000 RESEARCH & SCIENTIFIC AWARDS EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIU 3 230000 CHECK 0 RESEARCH & SCIENTIFIC AWARDS EAST ASIA AND THE PACIFIC 1 120000 CHECK 0 RESEARCH & SCIENTIFIC AWARDS NORTH AMERICA 3 40000 CHECK 0 PRE-POST DOCTORAL FELLOWSHIPS EUROPE (INCLUDING ICELAND & GREENLAND) 1 250000 CHECK 0 CAREER DEVELOPMENT AWARDS EAST ASIA AND THE PACIFIC 2 406000 CHECK 0 CAREER DEVELOPMENT AWARDS SUB-SAHARAN AFRICA 4 220000 CHECK 0 0 0 0 0 0 0 PART I, LINE 2: ALL GRANTEES ARE REQUIRED TO PROVIDE YEARLY PROGRESS REPORTS. ALL BUDGET ITEMS MUST BE JUSTIFIED IN CONNECTION WITH THE PROGRAM GUIDELINES; ANY DISCREPANCY OR UNEXPECTED FUNDS MUST BE RETURNED TO THE GRANTOR. PART I, LINE 3: THE ORGANIZATION USES THE ACCRUAL METHOD TO ACCOUNT FOR EXPENDITURES. PART III ACCOUNTING METHOD: 1 RESEARCH GRANTS 31 14054702 CAREER DEVELOPMENT AWARDS 19 5024000 PRE & POST DOCTORAL FELLOWSHIPS 5 1525000 SCIENTIFIC AWARDS 21 615000 TRAVEL AWARDS 324 491895 PART I, LINE 2: ALL GRANTEES ARE REQUIRED TO PROVIDE YEARLY PROGRESS REPORTS. ALL BUDGET ITEMS MUST BE JUSTIFIED IN CONNECTION WITH THE PROGRAM GUIDELINES; ANY DISCREPANCY OR UNEXPECTED FUNDS MUST BE RETURNED TO THE GRANTOR. X X 1 1 X X X X 0 0 0 0 0 0 0 0 0 DR MARGARET FOTI CHIEF EXECUTIVE OFFICER 765000 85000 0 0 131040 14560 21960 2440 29723 3303 947723 105303 0 0 MICHAEL STEWART VICE PRESIDENT, CHIEF FINANCIAL OFFI 369075 19425 0 0 0 0 29526 1554 21039 1107 419640 22086 0 0 JON RETZLAFF VP. SCIENCE POLICY & GOV. AFFAIRS, C 368000 0 0 0 0 0 29440 0 17232 0 414672 0 0 0 CHRISTINE BATTLE VP. SCIENTIFIC PUBLICATIONS, PUBLISH 290000 0 0 0 0 0 23200 0 17788 0 330988 0 0 0 PAUL DRISCOLL VP. MARKETING AND CREATIVE SERVICES 280000 0 0 0 0 0 22400 0 26057 0 328457 0 0 0 YIXIAN ZHANG SR. DIRECTOR / SCIENTIFIC REVIEW AND 270000 0 0 0 0 0 21600 0 26056 0 317656 0 0 0 RICHARD BUCK VP. COMMUNICATION 270000 0 0 0 0 0 21600 0 21023 0 312623 0 0 0 JOSEPH PONTOSKI SR. MANAGING DIRECTOR / FINANCE 269000 0 0 0 0 0 21120 0 21023 0 311143 0 0 0 MARY BALLINGER MNG. DIRECTOR / MEETINGS AND EXHIBIT 230000 0 0 0 0 0 18400 0 20771 0 269171 0 0 0 PART I, LINE 1A SCHEDULE J, PART I, LINE 1A: FIRST-CLASS OR CHARTER TRAVEL IT IS THE POLICY OF THE ASSOCIATION TO AUTHORIZE FIRST CLASS TRAVEL ARRANGEMENTS FOR THE CHIEF EXECUTIVE OFFICER IN ORDER TO ACCOMMODATE BUSINESS TRAVEL SCHEDULES AND FACILITATE ONGOING BUSINESS TRANSACTIONS. SCHEDULE J, PART II: OTHER REPORTABLE COMPENSATION THE EMPLOYMENT CONTRACT FOR THE AACR CEO CALLS FOR ANNUAL CONTRIBUTIONS TO A DEFERRED COMPENSATION PLAN. DUE TO STATUTORY AND AND REGULATORY REQUIREMENTS, A PORTION OF THESE ANNUAL PAYMENTS CAN NO LONGER BE DEFERRED INTO A QUALIFIED PLAN AND MUST BE PAID OUT ANNUALLY AND CLASSIFIED AS OTHER REPORTABLE COMPENSATION. IN ADDITION, THE COMPANY PROVIDES AN ANNUAL CAR ALLOWANCE THAT IS ALSO INCLUDED AS PART OF OTHER COMPENSATION. FORM 990, PART VI, SECTION A, LINE 6 MEMBERS THE ORGANIZATION HAS ONE CLASS OF VOTING MEMBER. EACH VOTING MEMBER IS ELIGIBLE TO VOTE OR TO HOLD THE OFFICE AND HAS THE SAME VOTING RIGHT - ONE VOTE PER MEMBER. FORM 990, PART VI, SECTION A, LINE 7A ELECTION OF MEMBERS OF GOVERNING BODY ELECTION OF MEMBERS OF THE GOVERNING BODY SHALL BE BY BALLOT DISTRIBUTED TO VOTING MEMBERS OF THE ORGANIZATION. THE CANDIDATE RECEIVING THE HIGHEST NUMBER OF VOTES CAST SHALL BE ELECTED. FORM 990, PART VI, SECTION A, LINE 7B GOVERNING BODY DECISIONS SUBJECT TO APPROVAL BY MEMBERS DECISIONS OF THE BOARD TO AMEND THE BY-LAWS OR TO AUTHORIZE THE ESTABLISHMENT OF A LOCAL SECTION REQUIRE APPROVAL BY MEMBERSHIP OF THE ASSOCIATION. FORM 990, PART VI, SECTION B, LINE 11B GOVERNING BODY REVIEW OF FORM 990 PRIOR TO ITS FILING WITH THE IRS, A COPY OF THE FINAL FORM 990 IS PROVIDED TO EACH VOTING MEMBER OF THE GOVERNING BODY AND TO THE FINANCE AND AUDIT COMMITTEE ON AN ANNUAL BASIS AS PART OF THEIR FIDUCIARY RESPONSIBILITY TO UNDERSTAND AND REVIEW THE ORGANIZATION'S FINANCES. FORM 990, PART VI, SECTION B, LINE 12C MONITORING AND ENFORCEMENT OF CONFLICT OF INTEREST POLICY EACH VOTING MEMBER OF THE GOVERNING BODY IS REQUIRED TO ANNUALLY ACKNOWLEDGE ANY CONFLICTS BY SIGNING THE CORPORATE CONFLICT OF INTEREST STATEMENT AND DETAILING ALL POTENTIAL CONFLICTS. FORM 990, PART VI, SECTION B, LINE 15 PROCESS FOR DETERMINING COMPENSATION INDEPENDENT DATA DETAILING COMPARABLE COMPENSATION IS PURCHASED ANNUALLY AND PROVIDED TO A COMPENSATION COMMITTEE WHICH EVALUATES SALARY LEVELS IN COMPARISON TO PEER GROUPS. FORM 990, PART VI, SECTION C, LINE 19 PUBLIC AVAILABILITY OF OTHER DOCUMENTS THE FINANCIAL STATEMENTS AND FORM 990 ARE POSTED ON THE ORGANIZATION'S WEBSITE (WWW.AACR.ORG). THEY WILL BE PROVIDED ON REQUEST, AND ARE ALSO AVAILABLE FOR INSPECTION AT THE ORGANIZATION'S OFFICE. FORM 990, PART VII, SECTION A, COMPENSATION FROM RELATED ORGANIZATION FOR THE CEO AND CFO, THE ALLOCATION IS BASED UPON AN ESTIMATE OF THE AMOUNT OF THEIR TIME SPENT IN THIS AREA - 10% FOR THE CEO, 5% FOR THE CFO. FORM 990, PART XI, LINE 9: CHANGE IN INTEREST IN NET ASSETS OF AFFILIATE-WITHOUT DONOR RESTRICTIONS -111,333. CHANGE IN INTEREST IN NET ASSETS OF AFFILIATE-WITH DONOR RESTRICTIONS -663,588. RETURN OF UNDISTRIBUTED PLEDGES -1,209,600. SCHEDULE R, PART II, COL B: PRIMARY ACTIVITY THE PURPOSE OF THE AACR FOUNDATION IS TO RAISE FUNDS AND SOLICIT GRANTS AND CONTRIBUTIONS TO BENEFIT, SUPPORT AND PROMOTE ITS PARENT ORGANIZATION - AACR'S MISSION IS DESCRIBED ON PAGE 2, PART III. THE PURPOSE OF AACR INTERNATIONAL - CANADA IS TO PROMOTE HEALTH BY SUPPORTING, MANAGING AND CONDUCTING NEW AND INNOVATIVE RESEARCH FOR THE CURE, PREVENTION AND TREATMENT OF CANCER, AND BY FOSTERING COLLABORATION AMONGST SCIENTISTS ENGAGED IN CANCER RESEARCH. IT INTENDS TO ADVANCE EDUCATION BY DEVELOPING AND OPERATING PROGRAMS, CONFERENCES, SEMINARS AND WORKSHOPS DESIGNED TO TRAIN STUDENTS AND SCIENTISTS AND ADVANCE THEIR UNDERSTANDING OF CANCER ETIOLOGY, PREVENTION, DIAGNOSIS AND TREATMENT. AMERICAN ASSOCIATION FOR CANCER RESEARCH FOUNDATION 615 CHESTNUT STREET 17TH FLOOR PHILADELPHIA PA 19106 233100004 SEE SCHEDULE O FOR DETAILS PA 501(C)(3) LINE 12A, I AMERICAN ASSOCIATION FOR CANCER RESEARCH INC 1 AMERICAN ASSOCIATION FOR CANCER RESEARCH INTERNATIONAL - CANADA C/O TMF CANADA MANAGEMENT INC 330 TORONTO ONTARIO CA SEE SCHEDULE O FOR DETAILS CA 501(C)(3) LINE 10 AMERICAN ASSOCIATION FOR CANCER RESEARCH INC 1 0 0 1 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 0 AMERICAN ASSOCIATION FOR CANCER RESEARCH FOUNDATION (SUPPORTING ORG) C 25847121 ACCRUAL METHOD AMERICAN ASSOCIATION FOR CANCER RESEARCH FOUNDATION (SUPPORTING ORG) R 1253000 ACCRUAL METHOD